NSAIDs for heavy menstrual bleeding

In: Canadian Family Physician · 2021 · vol. 67(8) , pp. 598 · doi:10.46747/cfp.6708598 · PMID:34385207 · W3192653147
article OA: diamond CC0 ⤵ 1 in-corpus citation
AI-generated summary by claude@2026-06, 2026-06-08

Nonsteroidal anti-inflammatory drugs reduced relative mean menstrual blood loss by approximately 30% and decreased sanitary product use by 20% to 50% in premenopausal women with heavy menstrual bleeding.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In premenopausal heavy menstrual bleeding without pathologic cause, do nonsteroidal anti-inflammatory drugs (NSAIDs) improve patient outcomes? Based on low-quality evidence, NSAIDs reduce relative mean menstrual blood loss by about 30%, and about 20% to 50% fewer sanitary products are used than

My notes (saved in your browser only)

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (13)

Cited by (1)

SciLite annotations

chemicals 6
mefenamic acid naproxen ibuprofen levonorgestrel progestin tranexamic acid

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
scilite
last seen: 2026-05-18T04:57:49.680383+00:00
License: CC0 · commercial use OK